Close Menu

NEW YORK – German startup Osteolabs announced on Monday its first commercialization agreements covering Germany and Turkey.

In Germany, Osteolabs has signed a deal with Eurofins LifeCodexx to commercialize Osteolabs' diagnostic test for the early detection of osteoporosis. The company has reached a similar deal in Turkey with BioGen Medical.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.